MedPath

Effect of Peppermint (Mentha Piperita) on severity of symptoms in patients with irritable bowel syndrome

Not Applicable
Recruiting
Conditions
Irritable bowel syndrome.
Irritable bowel syndrome
Registration Number
IRCT20130731014229N10
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

The desire to participate in the study
Aged 18 to 65
Gastrointestinal intestinal syndrome is diagnosed by a gastroenterologist

Exclusion Criteria

history of any major bowel surgery
metabolic diseases or other diseases
taking corticosteroids
taking Non-steroidal anti-inflammatory drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of symptoms of irritable bowel syndrome. Timepoint: Before the intervention and one month after the intervention. Method of measurement: Gastrointestinal Symptom Rating Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath